1. Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry. Issue 9 (20th August 2019) Authors: Loftus, Edward V; Reinisch, Walter; Panaccione, Remo; Berg, Sofie; Alperovich, Gabriela; Bereswill, Mareike; Kalabic, Jasmina; Petersson, Joel; Thakkar, Roopal; Robinson, Anne M; D'Haens, Geert Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 9(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adalimumab Effectiveness Up to Six Years in Adalimumab-naïve Patients with Crohn's Disease: Results of the PYRAMID Registry. Issue 9 (8th February 2019) Authors: Loftus, Edward V; Reinisch, Walter; Panaccione, Remo; Berg, Sofie; Alperovich, Gabriela; Bereswill, Mareike; Kalabic, Jasmina; Petersson, Joel; Thakkar, Roopal; Robinson, Anne M; D'Haens, Geert Journal: Inflammatory bowel diseases Issue: Volume 25:Issue 9(2019) Page Start: 1522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adalimumab Long‐term Effectiveness in Adalimumab‐Naive Patients With Crohn's Disease: Final Data From PYRAMID Registry: 657. (October 2017) Authors: Loftus, Edward V.; D'Haens, Geert; Reinisch, Walter; Satsangi, Jack; Panaccione, Remo; Berg, Sofie; Alperovich, Gabriela; Bereswill, Mareike; Kalabic, Jasmina; Skup, Martha; Petersson, Joel; Robinson, Anne M. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bridging Fixed Dose to Body Weight-based Regimen of Adalimumab in Paediatric Ulcerative Colitis Using a Pharmacometric Modelling Approach: Case Study with the Phase 3 ENVISION I Trial. (8th May 2022) Authors: Stodtmann, Sven; Chen, Mong-Jen; Siovitz, Lucia; Bereswill, Mareike; Lazar, Andreas; Croft, Nicholas; Kierkus, Jaroslaw; Faubion, William A; Mostafa, Nael M Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 10(2022) Page Start: 1551 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effect of Adalimumab on Clinical Outcomes and Health-related Quality of Life Among Patients With Ulcerative Colitis in a Clinical Practice Setting: Results From InspirADA. (17th July 2017) Authors: Travis, Simon; Feagan, Brian G; Peyrin-Biroulet, Laurent; Panaccione, Remo; Danese, Silvio; Lazar, Andreas; Robinson, Anne M; Petersson, Joel; Pappalardo, Brandee L; Bereswill, Mareike; Chen, Naijun; Wang, Song; Skup, Martha; Thakkar, Roopal B; Chao, Jingdong Journal: Journal of Crohn's and colitis Issue: Volume 11:Number 11(2017:Nov.) Page Start: 1317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy and safety of adalimumab in paediatric patients with moderate-to-severe ulcerative colitis (ENVISION I): a randomised, controlled, phase 3 study. (August 2021) Authors: Croft, Nicholas M; Faubion, William A; Kugathasan, Subra; Kierkus, Jaroslaw; Ruemmele, Frank M; Shimizu, Toshiaki; Mostafa, Nael M; Venetucci, Mary; Finney-Hayward, Tricia; Sanchez Gonzalez, Yuri; Bereswill, Mareike; Lazar, Andreas; Turner, Dan Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 8(2021) Page Start: 616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Observational data from the adalimumab post‐marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysis. Issue 5 (13th May 2022) Authors: Hart, Ailsa; D'Haens, Geert; Bereswill, Mareike; Finney‐Hayward, Tricia; Kalabic, Jasmina; Levy, Gweneth; Liang, Huifang; Seow, Cynthia H.; Loftus, Edward V.; Panaccione, Remo; Reinisch, Walter; Satsangi, Jack Journal: United European Gastroenterology journal Issue: Volume 10:Issue 5(2022) Page Start: 485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Open: Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow‐up in the PYRAMID Registry. (June 2018) Authors: D'Haens, Geert; Reinisch, Walter; Panaccione, Remo; Satsangi, Jack; Petersson, Joel; Bereswill, Mareike; Arikan, Dilek; Perotti, Eva; Robinson, Anne M; Kalabic, Jasmina; Alperovich, Gabriela; Thakkar, Roopal; Loftus, Edward V Journal: American journal of gastroenterology Issue: Volume 113:Number 6(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PYRAMID Registry: Long‐term Safety and Effectiveness of Adalimumab by Baseline Immunomodulator Use in Patients With Crohn's Disease: 694. (October 2017) Authors: Reinisch, Walter; Panaccione, Remo; D'Haens, Geert; Loftus, Edward V.; Satsangi, Jack; Colombel, Jean‐Frederic; Alperovich, Gabriela; Berg, Sofie; Kalabic, Jasmina; Bereswill, Mareike; Petersson, Joel; Robinson, Anne M. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. PYRAMID Registry: Long‐term Safety of Adalimumab by Age in Patients With Crohn's Disease: 717. (October 2017) Authors: Colombel, Jean‐Frederic; D'Haens, Geert; Reinisch, Walter; Loftus, Edward V.; Panaccione, Remo; Satsangi, Jack; Alperovich, Gabriela; Berg, Sofie; Kalabic, Jasmina; Bereswill, Mareike; Petersson, Joel; Robinson, Anne M. Journal: American journal of gastroenterology Issue: Volume 112(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗